糖心vlog

[Skip to Navigation]
Sign In

October 2024 - January 1920

Decade

Year

Issue

August 2023, Vol 159, No. 8, Pages 803-893

Viewpoint

Research Fever in Dermatology鈥擜 Symptom of a Larger Problem

Abstract Full Text
JAMA Dermatol. 2023;159(8):805-806. doi:10.1001/jamadermatol.2023.1690

This Viewpoint offers potential solutions to research 鈥渇ever,鈥 which is characterized as a symptom of larger problems in our health care and educational systems rather than the fault of residency applicants.

Editorial

Exploring Discordance Between Patients and Clinicians鈥擴nderstanding Perceived Disease Severity

Abstract Full Text
JAMA Dermatol. 2023;159(8):807-809. doi:10.1001/jamadermatol.2023.2007
Original Investigation

Understanding Discordant Perceptions of Disease Severity Between Physicians and Patients With Eczema and Psoriasis Using Structural Equation Modeling

Abstract Full Text
free access
JAMA Dermatol. 2023;159(8):811-819. doi:10.1001/jamadermatol.2023.2008

This cross-sectional study tests and validates a model explaining the cognitive, behavioral, and disease factors associated with discordant severity grading between physicians and patients with eczema and psoriasis.

Hyperactivation of the JAK2/STAT5 Signaling Pathway and Evaluation of Baricitinib Treatment Among Patients With Eosinophilic Cellulitis

Abstract Full Text
free access
JAMA Dermatol. 2023;159(8):820-829. doi:10.1001/jamadermatol.2023.1651

This case series examines hyperactivation of the JAK2/STAT5 signaling pathway in patients with eosinophilic cellulitis and evaluates outcomes associated with baricitinib treatment.

Assessment of Need for Improved Identification of a Culprit Drug in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis

Abstract Full Text
free access
JAMA Dermatol. 2023;159(8):830-836. doi:10.1001/jamadermatol.2023.1693

This cohort study examines patient allergy list outcomes, current approaches in identifying culprit drugs, and potential methods of improving culprit drug identification for patients with Stevens-Johnson syndrome/toxic epidermal necrolysis.

Cutaneous Manifestations, Clinical Characteristics, and Prognosis of Patients With Systemic Sclerosis Sine Scleroderma: Data From the International EUSTAR Database

Abstract Full Text
free access
JAMA Dermatol. 2023;159(8):837-847. doi:10.1001/jamadermatol.2023.1729

This cohort study characterizes the clinical phenotype of systemic sclerosis sine scleroderma vs limited cutaneous and diffuse cutaneous systemic sclerosis within the EUSTAR database.

Patient Preferences for Pain Control After Mohs Micrographic Surgery: A Single-Center Discrete Choice Experiment

Abstract Full Text
free access
JAMA Dermatol. 2023;159(8):848-853. doi:10.1001/jamadermatol.2023.1899

This prospective discrete choice experiment investigated how the perceived risk of opioid addiction may be associated with patient preferences for pain management after Mohs surgery.

Brief Report

High-risk Prognostic Tumor Features of Squamous Cell Carcinomas in Organ Transplant Recipients Compared With the General Population

Abstract Full Text
JAMA Dermatol. 2023;159(8):854-858. doi:10.1001/jamadermatol.2023.1574

This dual-cohort study quantifies the frequency of perineural invasion, invasion below the dermis, lack of cellular differentiation, and large tumor diameter in squamous cell carcinomas in organ transplant recipients and the general population.

Trends Over Time in Medicare for Advanced Practice Clinicians in Dermatology, 2013-2020

Abstract Full Text
JAMA Dermatol. 2023;159(8):859-863. doi:10.1001/jamadermatol.2023.1843

This cohort study evaluates the contribution of advanced practice clinicians, including nurse practitioners and physician assistants, to the dermatology workforce and how this has changed over time.

Clinical and Pathological Spectrum of Prurigo Pigmentosa in Central European Individuals

Abstract Full Text
JAMA Dermatol. 2023;159(8):864-869. doi:10.1001/jamadermatol.2023.1917

This case series aims to increase awareness of prurigo pigmentosa by describing the clinical, histopathological, and immunohistochemical features of the disease in central European individuals.

Review

Chemotherapy-Induced Pseudocellulitis Without Prior Radiation Exposure: A Systematic Review

Abstract Full Text
has active quiz
JAMA Dermatol. 2023;159(8):870-874. doi:10.1001/jamadermatol.2023.1735

This systematic review of case reports seeks to differentiate chemotherapy-induced pseudocellulitis from infectious cellulitis and to improve the diagnosis and care of this condition among patients undergoing oncologic treatment.

Images in Dermatology

Erythrokeratodermia

Abstract Full Text
has active quiz
JAMA Dermatol. 2023;159(8):875-876. doi:10.1001/jamadermatol.2023.0117

This case report describes well-defined, polycyclic, and geographic hyperkeratotic plaques that involved the axillae, chest, flanks, inguinal folds, and buttocks.

Trichothiodystrophy

Abstract Full Text
has active quiz
JAMA Dermatol. 2023;159(8):877. doi:10.1001/jamadermatol.2023.0913

This case report describes an infant with frizzy, coarse, and fragile hair and low-set ears, blepharophimosis, and osteopenia.

JAMA Dermatology Clinicopathological Challenge

Treatment-Resistant Edematous Annular Plaques and Mild Leukopenia in a Man in His 60s

Abstract Full Text
has active quiz
JAMA Dermatol. 2023;159(8):878-879. doi:10.1001/jamadermatol.2023.1591

A man in his 60s presented with a 5-year history of diffuse erythematous, edematous annular plaques, low-grade fevers, and mild leukopenia. What is your diagnosis?

Progressive Generalized Skin Laxity in a Young Woman

Abstract Full Text
has active quiz
JAMA Dermatol. 2023;159(8):880-881. doi:10.1001/jamadermatol.2023.1671

A Chinese woman in her late 20s presented with a 20-year history of progressive skin laxity. What is your diagnosis?

Research Letter

Prevalence of Crohn Disease Among Pediatric Patients With Hidradenitis Suppurativa

Abstract Full Text
free access
JAMA Dermatol. 2023;159(8):883-884. doi:10.1001/jamadermatol.2023.1585

This cross-sectional study compares the prevalence of Crohn disease among US pediatric patients with and without hidradenitis suppurativa.

Prevalence of Atopic Diseases Among Sexually Diverse Adults in the US

Abstract Full Text
free access
JAMA Dermatol. 2023;159(8):884-887. doi:10.1001/jamadermatol.2023.1934

This cross-sectional study assesses the prevalence of asthma, allergic rhinitis, or atopic dermatitis among sexually diverse adults compared with heterosexual adults in the US.

Observation

Emergence of Malignant T-Cell Intraclonal CDR3 Variants in Mycosis Fungoides

Abstract Full Text
JAMA Dermatol. 2023;159(8):888-890. doi:10.1001/jamadermatol.2023.0826

This case report describes 3 patients with mycosis fungoides with CDR3 variants.

Intralesional Certolizumab for Refractory Lupus Pernio

Abstract Full Text
JAMA Dermatol. 2023;159(8):890-891. doi:10.1001/jamadermatol.2023.0987

This case report describes a patient with refractory lupus pernio that responded to treatment with a series of intralesional certolizumab injections.

Comment & Response

Nutritional Supplements and Hair Loss鈥擫imitations to the Interpretation of Clinical Studies Before Implementation in Clinical Practice

Abstract Full Text
JAMA Dermatol. 2023;159(8):891-892. doi:10.1001/jamadermatol.2023.1776

Nutritional Supplements and Hair Loss鈥擫imitations to the Interpretation of Clinical Studies Before Implementation in Clinical Practice

Abstract Full Text
JAMA Dermatol. 2023;159(8):892-893. doi:10.1001/jamadermatol.2023.1779

Nutritional Supplements and Hair Loss鈥擫imitations to the Interpretation of Clinical Studies Before Implementation in Clinical Practice鈥擱eply

Abstract Full Text
JAMA Dermatol. 2023;159(8):893. doi:10.1001/jamadermatol.2023.1762
JAMA Dermatology Masthead

JAMA Dermatology

Abstract Full Text
free access
JAMA Dermatol. 2023;159(8):803. doi:10.1001/jamadermatol.2022.4424
×